Targeted genetic screen in Amyotrophic Lateral Sclerosis reveals novel genetic variants with syngergistic effect on clinical phenotypehas been published in the journal Frontiers in Molecular Neuroscience. This work was supported in part by the SOPHIA project, selected in the 2011 Biomarkers call, the STRENGTH project, selected in the 2012 Risk Factors call and the ALS-CarE project, selected in the 2012 Healthcare Evaluation call.